Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06422273 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Protest Trial: TXA vs Saline

StatusEnrolling by Invitation
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 6 months later Jun 30, 2026 → Dec 30, 2026
See other at-risk trials from Corewell Health West

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jun 30, 2026 to Dec 30, 2026
    • Study completion pushed from Jun 30, 2027 to Dec 30, 2027
    v7
  2. Study site revisedv6
  3. Study site revisedv5
  4. Re-verified, no change to tracked fieldsv4
  5. Primary completion date: Apr 30, 2025 to Jun 30, 2026
    • Study completion date: Apr 30, 2026 to Jun 30, 2027
    v3
  6. Re-verified, no change to tracked fieldsv2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To determine if endobronchial (topical) tranexamic acid used prophylactically prior to performing transbronchial biopsies in lung transplant recipients reduces bleeding risk.
Trial Details
NCT Number NCT06422273
Lead Sponsor Corewell Health West
Conditions
(from sponsor)		 Lung Transplant, Complications Surgical
Enrollment 94 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov